Literature DB >> 32171783

Circadian and sleep dysfunction in Alzheimer's disease.

Md Sahab Uddin1, Devesh Tewari2, Abdullah Al Mamun3, Md Tanvir Kabir4, Kamal Niaz5, Mir Imam Ibne Wahed6, George E Barreto7, Ghulam Md Ashraf8.   

Abstract

Alzheimer's disease (AD) is a devastating and irreversible cognitive impairment and the most common type of dementia. Along with progressive cognitive impairment, dysfunction of the circadian rhythms also plays a pivotal role in the progression of AD. A mutual relationship among circadian rhythms, sleep, and AD has been well-recommended. The etiopathogenesis of the disturbances of the circadian system and AD share some general features that also unlock the outlook of observing them as a mutually dependent pathway. Indeed, the burden of amyloid β (Aβ), neurofibrillary tangles (NFTs), neuroinflammation, oxidative stress, and dysfunction of circadian rhythms may lead to AD. Aging can alter both sleep timings and quality that can be strongly disrupted in AD. Increased production of Aβ and reduced Aβ clearance are caused by a close interplay of Aβ, sleep disturbance and raised wakefulness. Besides Aβ, the impact of tau pathology is possibly noteworthy to the sleep deprivation found in AD. Hence, this review is focused on the primary mechanistic complexities linked to disruption of circadian rhythms, sleep deprivation, and AD. Furthermore, this review also highlights the potential therapeutic strategies to abate AD pathogenesis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid β; Circadian rhythms; Neurofibrillary tangles; Sleep

Year:  2020        PMID: 32171783     DOI: 10.1016/j.arr.2020.101046

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  25 in total

Review 1.  Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.

Authors:  Md Sahab Uddin; Dewan Md Sumsuzzman; Philippe Jeandet; Tapan Behl; Abdur Rauf; Md Shah Amran; Ghulam Md Ashraf
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

Review 2.  Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Sonia Zaman; Yesmin Begum; Ghulam Md Ashraf; May N Bin-Jumah; Simona G Bungau; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-05       Impact factor: 5.590

Review 3.  Possible Neuropathology of Sleep Disturbance Linking to Alzheimer's Disease: Astrocytic and Microglial Roles.

Authors:  Shu-Yun Xiao; Yi-Jie Liu; Wang Lu; Zhong-Wei Sha; Che Xu; Zhi-Hua Yu; Shin-Da Lee
Journal:  Front Cell Neurosci       Date:  2022-06-09       Impact factor: 6.147

4.  MRI-visible enlarged perivascular spaces: imaging marker to predict cognitive impairment in older chronic insomnia patients.

Authors:  Xin-Xin Wang; Qin-Chen Cao; Jun-Fang Teng; Rui-Fang Wang; Zi-Tao Yang; Meng-Ge Wang; Zheng-Hao Cao
Journal:  Eur Radiol       Date:  2022-03-14       Impact factor: 7.034

Review 5.  Toward noninvasive brain stimulation 2.0 in Alzheimer's disease.

Authors:  Arianna Menardi; Simone Rossi; Giacomo Koch; Harald Hampel; Andrea Vergallo; Michael A Nitsche; Yaakov Stern; Barbara Borroni; Stefano F Cappa; Maria Cotelli; Giulio Ruffini; Georges El-Fakhri; Paolo M Rossini; Brad Dickerson; Andrea Antal; Claudio Babiloni; Jean-Pascal Lefaucheur; Bruno Dubois; Gustavo Deco; Ulf Ziemann; Alvaro Pascual-Leone; Emiliano Santarnecchi
Journal:  Ageing Res Rev       Date:  2021-12-30       Impact factor: 11.788

Review 6.  Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Ghulam Md Ashraf; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

7.  Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.

Authors:  Muhamed N H Eeza; Rico Singer; Corinna Höfling; Jörg Matysik; Huub J M de Groot; Steffen Roβner; A Alia
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.

Authors:  Carsten T Beuckmann; Hiroyuki Suzuki; Erik S Musiek; Takashi Ueno; Toshitaka Sato; Masahiro Bando; Yoshihide Osada; Margaret Moline
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 9.  Combination Drug Therapy for the Management of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Abdullah Al Mamun; Philippe Jeandet; Lotfi Aleya; Rasha A Mansouri; Ghulam Md Ashraf; Bijo Mathew; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

Review 10.  Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Philippe Jeandet; Bijo Mathew; Ghulam Md Ashraf; Asma Perveen; May N Bin-Jumah; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2020-04-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.